2000•Zhonghua neifenmi daixie zazhiRequires access

Effect of angiotensin II receptor antagonist on the plasma levels of calcitonin gene-related peptide and endothelin in the patients with diabetic nephrophy

Cui-ping Cao, Guoliang Liu, Binhong Wen

Open publisher page 0 citations

Abstract

The plasma levels of calcitonin gene-related peptide (CGRP) and endothelin (ET) were assayed in 76 patients with diabetic nephropathy (DN) and 23 healthy subjects, and the changes of CGRP and ET levels after treatment with angiotensin Ⅱ receptor antagonist (ARBS) were observed. The results showed that CGRP level was increased and ET level decreased after treatment with ARBS, which seemed to delay the onset and development of DN.

About this research paper

What this paper is about

The plasma levels of calcitonin gene-related peptide (CGRP) and endothelin (ET) were assayed in 76 patients with diabetic nephropathy (DN) and 23 healthy subjects, and the changes of CGRP and ET levels after treatment with angiotensin Ⅱ receptor antagonist (ARBS) were observed. The results showed that CGRP level was increased and ET level decreased after treatment with ARBS, which seemed to delay the onset and development of DN.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The plasma levels of calcitonin gene-related peptide (CGRP) and endothelin (ET) were assayed in 76 patients with diabetic nephropathy (DN) and 23 healthy subjects, and the changes of CGRP and ET levels after treatment with angiotensin Ⅱ receptor antagonist (ARBS) were observed. The results showed that CGRP level was increased and ET level decreased after treatment with ARBS, which seemed to delay the onset and development of DN.

Key concepts: Calcitonin gene-related peptide, Endocrinology, Internal medicine, Endothelin receptor, Calcitonin, Antagonist, Diabetic nephropathy, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of angiotensin II receptor antagonist on the plasma levels of calcitonin gene-related peptide and endothelin in the patients with diabetic nephrophy — Research Paper | ScholarLens